The FDA premarket approval records linked to Biosense Webster, Inc. describe a cardiac electrophysiology device family spanning focal and navigation catheters for atrial fibrillation and atrial flutter ablation. The records identify the applicant at an Irvine, California address and list the products under device product codes QZI, OAE, OAD and LPB. The filings below are dated 2026 and cover labeling and supplier changes rather than new device approvals. [1][2][3][4][5]
Documented catheter products and technology
The Varipulse Bi-Directional Catheter is recorded under product code QZI with the generic name percutaneous cardiac ablation catheter for treatment of atrial fibrillation with irreversible electroporation. The FDA summary of safety and effectiveness for P240006 names the broader VARIPULSE Platform, listing the VARIPULSE Catheter, TRUPULSE Generator, Sterile Interface Cable and nGEN Pump as its components. [1][9]
Other records cover the QDOT MICRO Bi-Directional and Uni-Directional Navigation Catheters under product code OAE, the THERMOCOOL SMARTTOUCH Bi-Directional and Uni-Directional Navigation Catheters under LPB, and the EZ STEER THERMOCOOL NAV Bi-Directional Electrophysiology Catheter together with the THERMOCOOL SMARTTOUCH Bi-Directional Navigation Catheter under OAD. The OAD generic name describes a percutaneous cardiac ablation catheter for treatment of atrial flutter. [3][4][5]
Labeling change on the Varipulse catheter
Supplement P240006/S018 to the Varipulse Bi-Directional Catheter was received on August 3, 2026 and decided on November 3, 2026 with an approval decision code. The FDA record describes the action as an extension of the product shelf-life from one year to three years, filed as a real-time process supplement under the reason labeling change covering indications, instructions, shelf life or tradename. The advisory committee is listed as Cardiovascular. [1]
Supplier notices decided in September 2026
Four 30-day notices were received on August 18, 2026 and decided on September 15, 2026: P240006/S020 for the Varipulse Bi-Directional Catheter, P030031/S146 for the EZ STEER THERMOCOOL NAV and THERMOCOOL SMARTTOUCH catheters, P210027/S019 for the QDOT MICRO catheters and P040036/S101 for the THERMOCOOL SMARTTOUCH catheters. Each record states the action as an additional supplier for critical components, under the reason process change covering manufacturer, sterilizer, packager or supplier. [2][3][4][5]
How the filing set is bounded
The linked collection holds 12 premarket approval records, six with an approval decision and six with a 30-day notice decision. The smaller record sample of five rows contains one approval and four 30-day notices. These counts describe the retrieved filings as of November 20, 2026 and are not measures of total portfolio size, sales or safety performance. No recall records appear in the retrieved set. [1][2][3][4][5]
The records name Biosense Webster, Inc. as applicant at Irvine, California addresses. That address is the filing address on FDA records and is not treated here as a verified headquarters. No parent company, brand ownership, website or commercial availability is confirmed by these documents, and the FDA summary of safety and effectiveness notes a November 6, 2024 approval date for P240006. [1][9]








